NanoVibronix Inc. Secures U.S. Patent for Pediatric Feeding Tube Guidance System

Reuters
11 Jun
<a href="https://laohu8.com/S/NAOV">NanoVibronix Inc</a>. Secures U.S. Patent for Pediatric Feeding Tube Guidance System

NanoVibronix Inc. announced that its ENvue Medical division has been granted a U.S. patent for its pediatric feeding tube guidance system. The patent, titled "Insertion Device Positioning Guidance System," enhances ENvue Medical's intellectual property portfolio and underscores the company's commitment to innovation in feeding tube placement technologies. This development is part of ENvue Medical's broader strategy to pursue U.S. FDA 510(k) clearance for pediatric use, building on its current FDA clearance for adult patients. The patented technology employs electromagnetic tracking to provide real-time visualization and confirmation of feeding tube positions, aiming to aid clinicians in pediatric settings and reduce the need for confirmatory imaging.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoVibronix Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250611129680) on June 11, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10